LncRNAs act as a link between chronic liver disease and hepatocellular carcinoma

25Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.

Abstract

Long non-coding RNAs (IncRNAs) are emerging as important contributors to the biological processes underlying the pathophysiology of various human diseases, including hepatocellular carcinoma (HCC). However, the involvement of these molecules in chronic liver diseases, such as nonalcoholic fatty liver disease (NAFLD) and viral hepatitis, has only recently been considered in scientific research. While extensive studies on the pathogenesis of the development of HCC from hepatic fibrosis have been conducted, their regulatory molecular mechanisms are still only partially understood. The underlying mechanisms related to lncRNAs leading to HCC from chronic liver diseases and cirrhosis have not yet been entirely elucidated. Therefore, elucidating the functional roles of lncRNAs in chronic liver disease and HCC can contribute to a better understanding of the molecular mechanisms, and may help in developing novel diagnostic biomarkers and therapeutic targets for HCC, as well as in preventing the progression of chronic liver disease to HCC. Here, we comprehensively review and briefly summarize some lncRNAs that participate in both hepatic fibrosis and HCC.

Cite

CITATION STYLE

APA

Kim, Y. A., Park, K. K., & Lee, S. J. (2020, April 2). LncRNAs act as a link between chronic liver disease and hepatocellular carcinoma. International Journal of Molecular Sciences. MDPI AG. https://doi.org/10.3390/ijms21082883

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free